| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 139,3 k € | -8.6% | 152,4 k € | -7.3% | 164,5 k € | +84.6% | 89,1 k € | +109.5% | 42,5 k € | -42.2% | 73,6 k € | -9.6% | 81,4 k € | -8.8% | 89,2 k € | -32.4% | 131,9 k € | +29.7% | 101,7 k € | +8.6% | 93,7 k € | -6.9% | 100,5 k € | |
| EBITDA | 137,6 k € | -9.3% | 151,6 k € | -6.6% | 162,3 k € | +84.3% | 88,0 k € | +109.1% | 42,1 k € | -42.4% | 73,1 k € | -9.6% | 80,9 k € | -8.9% | 88,8 k € | -32.5% | 131,5 k € | +29.8% | 101,3 k € | +8.7% | 93,2 k € | -6.6% | 99,8 k € | |
| Operating profit | 89,2 k € | -14.2% | 103,9 k € | -17.1% | 125,4 k € | +110.7% | 59,5 k € | +119.5% | 27,1 k € | -62.3% | 71,9 k € | -10.0% | 79,9 k € | -3.9% | 83,1 k € | -33.4% | 124,8 k € | +32.2% | 94,4 k € | +9.4% | 86,3 k € | -5.3% | 91,1 k € | |
| Profit/loss | 53,4 k € | -22.3% | 68,8 k € | -23.3% | 89,7 k € | +108.8% | 43,0 k € | +106.6% | 20,8 k € | -64.2% | 58,2 k € | -6.9% | 62,5 k € | -3.8% | 64,9 k € | -19.4% | 80,6 k € | +20.5% | 66,9 k € | +19.7% | 55,9 k € | -14.0% | 64,9 k € | |
| Equity | 296,2 k € | +22.0% | 242,7 k € | +39.5% | 174,0 k € | -66.8% | 523,3 k € | +8.9% | 480,3 k € | +4.5% | 459,5 k € | +14.5% | 401,3 k € | +18.4% | 338,9 k € | +23.7% | 273,9 k € | +41.7% | 193,3 k € | +46.0% | 132,4 k € | +73.0% | 76,5 k € | |
| Total assets | 525,6 k € | +5.7% | 497,3 k € | -22.7% | 643,6 k € | +18.3% | 544,1 k € | +11.9% | 486,2 k € | +5.3% | 461,7 k € | +14.8% | 402,2 k € | +12.0% | 359,1 k € | +12.5% | 319,2 k € | +40.7% | 226,8 k € | +39.0% | 163,2 k € | +47.2% | 110,9 k € | |
| Cash | 170,0 k € | +75.0% | 97,2 k € | -55.8% | 219,7 k € | +32.9% | 165,4 k € | +97.0% | 83,9 k € | -80.6% | 432,4 k € | +10.0% | 393,0 k € | +17.0% | 335,9 k € | +8.5% | 309,6 k € | +44.8% | 213,9 k € | +49.2% | 143,4 k € | +78.0% | 80,5 k € | |
| Debts | 229,4 k € | -9.9% | 254,5 k € | -45.8% | 469,6 k € | +2157.9% | 20,8 k € | +253.3% | 5,9 k € | +171.2% | 2,2 k € | +139.5% | 906,5 € | -95.5% | 20,2 k € | -55.5% | 45,3 k € | +35.2% | 33,5 k € | +8.8% | 30,8 k € | -10.3% | 34,4 k € | |
Private limited company · Hoogstraten · incorporated on 15/10/2013
Private limited company profitable and well capitalised. Cash position rising (+75.0%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DR. ANN STEPPE is a Private limited company incorporated in 2013. Its main activity is: Other human health activities. Its registered office is in Hoogstraten.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette